Stopping Alendronate in osteoporosis after no fractures
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study wants to see if it is safe for postmenopausal women with osteoporosis to stop taking Alendronate after a long period of treatment without any new fractures. If you have been on Alendronate for a while and have stayed fracture-free, you may be able to take a break from the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has gone through menopause.
- You are currently taking the bone medicine Alendronate.
- You have either taken it for more than 3 years without any broken bones, or for more than 5 years and your last low-energy fracture was over 3 years ago.
- Your bone density test (T-score) is above -3.5 in your hip or spine.
- You have not taken steroid medications (like prednisone) in the past year.
- You do not have any active uncontrolled diseases, cancer, or serious kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatment plans for women with osteoporosis to see which one improves hip bone density more. Participants will either get two medications in sequence (romosozumab followed by denosumab) or one medication (zoledronic acid), both given as injections or infusions. The goal is to find a treatment that reduces fracture risk.
This trial tests whether the drug alendronate can help prevent stress fractures (small breaks) in the pelvic bones of women with cervical cancer who are getting chemotherapy and radiation. It aims to reduce bone pain and improve bone health during treatment.
This study is a follow-up for people who completed a previous precision medicine trial for osteoporosis. It will monitor your bone health to see how well the treatment is working over time.
This trial studies whether doing a structured bone-focused exercise program, taking alendronate (a medication that slows bone loss), and making a calorie-reducing diet can improve bone strength in people with low bone density. It also compares different combinations to see what helps most and is safest for you.
This trial tests whether giving zoledronic acid (a bone-strengthening infusion) right after stopping denosumab can help prevent bone loss in women with post-menopausal osteoporosis. It may be a good option if you have finished at least 2 years of denosumab and your doctor says it's safe to stop.
This study aims to help adults over 50 who had a recent bone fracture (from a minor fall) get better follow-up care to prevent future fractures. You will work with a nurse or coordinator to connect with your primary care doctor and learn about bone health options.
Hear when a new Osteoporosis in Post-menopausal Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.